Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma

View/Open
Volume
16
DOI
10.1186/s12885-016-2289-y
Journal
BMC CANCER
ISSN
1471-2407
Metadata
Show full item record
Authors
Lisenko, K; McClanahan, F; Schoening, T; Schwarzbich, MA; Cremer, M; Dittrich, T; Ho, AD; Witzens-Harig, M
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/12244
Collections
Licence information
CC-BY
Copyright statements
© 2016 Lisenko et al.